Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -267.03 | -32.81 |
PEG Ratio (TTM) | 0.87 | -2.60 |
P/S Ratio (TTM) | N/A | 34.48 |
P/B Ratio (TTM) | 2.92 | 6.92 |
P/FCF Ratio (TTM) | -23.53 | -186.97 |
Price to 5YR AVG Earnings Ratio | N/A | -29.47 |
Price to 5YR AVG FCF Ratio | N/A | -26.96 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.80% | 47.18% |
ROE (TTM) | -0.45% | -531.00% |
Net Profit Margin (TTM) | N/A | -258.93% |
ROIC 5YR AVG | N/A | 831.88% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -100.04% | 384.23% | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -78.85% | 119.12% | N/A |
Cash Flow | -810.30% | -6,651.30% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.05 | 4.81 |
Quick Ratio (TTM) | 0.05 | 24.13 |
D/E Ratio (TTM) | 0.10 | 0.23 |
Interest Coverage (TTM) | N/A | 2.72 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 4.36 | 21.17 |
LTL to 5YR AVG FCF | N/A | -1.27 |
Shares Outstanding Growth 5YR AVG | N/A | 515.68% |